A breakthrough stroke treatment is saving lives. If you can get it in time.
It's known as endovascular thrombectomy—or EVT—and in the decade-plus since it was developed it has evolved to be something of a miracle for people unlucky enough to suffer a stroke, but lucky enough to be able to access it quickly. If performed in time it can turn a potentially deadly or life-altering stroke to something that can be rehabbed in a couple of weeks. But it's an incredibly complex procedure, there aren't expert teams able to handle it everywhere, and as we all know: when it comes to strokes, time is precious. So how does a complicated medical intervention get from a lifesaving specialty to globally available? And how many lives could be saved if it does? GUEST: Eva Holland, writing in The New York Times Magazine
Audio is streamed directly from the publisher (rogers.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
It's known as endovascular thrombectomy—or EVT—and in the decade-plus since it was developed it has evolved to be something of a miracle for people unlucky enough to suffer a stroke, but lucky enough to be able to access it quickly. If performed in time it can turn a potentially deadly or life-altering stroke to something that can be rehabbed in a couple of weeks.
But it's an incredibly complex procedure, there aren't expert teams able to handle it everywhere, and as we all know: when it comes to strokes, time is precious. So how does a complicated medical intervention get from a lifesaving specialty to globally available? And how many lives could be saved if it does?
GUEST: Eva Holland, writing in The New York Times Magazine
We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:
Through email at [email protected]
Or @thebigstory.bsky.social on Bluesky